drugset / Trial / NCT01938859

Algorithm Guided Treatment Strategies for Bipolar Depression

NCT01938859

Phase 4 Unknown 360 enrolled Shanghai Mental Health Center
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the AGTs-BD study is to compare the treatment outcome and safety profiles between different mood stabilizers combination treatments in the patients with bipolar disorders, currently suffered from depression episode.

Timeline

Start
2012-06
Primary completion
2017-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule 200 mg
Subject Quetiapine Small molecule 400 mg
Subject St. John's Wort Traditional medicine (herbal / TCM) 1440 mg
Background Lithium Unknown

Indications